Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 532

1.
3.

Combined transplantation of allogeneic bone marrow and CD34+ blood cells.

Link H, Arseniev L, Bähre O, Berenson RJ, Battmer K, Kadar JG, Jacobs R, Casper J, Kühl J, Schubert J, Diedrich H, Poliwoda H.

Blood. 1995 Oct 1;86(7):2500-8.

4.

Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.

Cao TM, Kusnierz-Glaz C, Valone F, Stockerl-Goldstein KE, Hu WW, Johnston L, Blume KG, Strober S, Negrin RS.

Cancer. 2001 Jun 15;91(12):2205-13.

PMID:
11413507
5.
7.

Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Ringdén O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E, Reiffers J, Arcese W, Vossen JM, Jouet JP, Cordonnier C, Frassoni F.

J Clin Oncol. 2004 Feb 1;22(3):416-23. Epub 2003 Dec 22.

PMID:
14691124
8.

A pilot study of allogeneic bone marrow transplantation using related donors stimulated with G-CSF.

Isola LM, Scigliano E, Skerrett D, Shank B, Ross V, Najfeld V, Fruchtman S.

Bone Marrow Transplant. 1997 Dec;20(12):1033-7.

9.

Treatment of poor marrow graft function with allogeneic CD34+ cells immunoselected from G-CSF-mobilized peripheral blood progenitor cells of the marrow donor.

Arseniev L, Tischler HJ, Battmer K, Südmeier I, Casper J, Link H.

Bone Marrow Transplant. 1994 Nov;14(5):791-7.

PMID:
7534162
10.

Transplantation of allogeneic CD34+ blood cells.

Link H, Arseniev L, Bähre O, Kadar JG, Diedrich H, Poliwoda H.

Blood. 1996 Jun 1;87(11):4903-9.

11.

A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignancies.

Cornelissen JJ, van der Holt B, Petersen EJ, Vindelov L, Russel CA, Höglund M, Maertens J, Schouten HC, Braakman E, Steijaert MM, Zijlmans MJ, Slaper-Cortenbach I, Boogaerts MA, Löwenberg B, Verdonck LF.

Exp Hematol. 2003 Oct;31(10):855-64.

PMID:
14550800
12.

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies.

Mavroudis D, Read E, Cottler-Fox M, Couriel D, Molldrem J, Carter C, Yu M, Dunbar C, Barrett J.

Blood. 1996 Oct 15;88(8):3223-9.

13.

[A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].

Chen Y, Huang X, Xu L, Liu D, Zhang Y, Ren H, Guo N, Lu D.

Zhonghua Yi Xue Za Zhi. 2002 Oct 10;82(19):1306-9. Chinese.

PMID:
12509932
14.

Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.

Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.

Haematologica. 1998 Jan;83(1):48-55.

15.

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.

Gürman G, Arat M, Ilhan O, Konuk N, Beksaç M, Celebi H, Ozcan M, Arslan O, Ustün C, Akan H, Uysal A, Koç H.

Cytotherapy. 2001;3(4):253-60.

PMID:
12171713
16.

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.

Körbling M, Huh YO, Durett A, Mirza N, Miller P, Engel H, Anderlini P, van Besien K, Andreeff M, Przepiorka D, Deisseroth AB, Champlin RE.

Blood. 1995 Oct 1;86(7):2842-8.

17.

Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation.

Lickliter JD, McGlave PB, DeFor TE, Miller JS, Ramsay NK, Verfaillie CM, Burns LJ, Wagner JE, Eastlund T, Dusenbery K, Weisdorf DJ.

Bone Marrow Transplant. 2000 Oct;26(7):723-8.

18.

[CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].

Sawada H, Wake A, Yamasaki Y, Izumi Y.

Rinsho Ketsueki. 2000 Jun;41(6):500-6. Japanese.

PMID:
10921350
20.

Low incidence of severe aGVHD and accelerating hemopoietic reconstitution in allo-BMT using lenograstim stimulated BM cells.

Ji S, Chen H, Wang H, Ma J, Pan S, Xue M, Zhu L, Liu J, Xiao M, Zhou L.

Chin Med J (Engl). 2001 Feb;114(2):191-5.

PMID:
11780205

Supplemental Content

Support Center